FDA: Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities. (U01) Clinical Trial Not Allowed

The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) is announcing its intent to solicit grant applications from neutral, independent institutions and/or organizations to support meetings (e.g., conferences workgroups, roundtables) that convene a broad range of multiple stakeholders, including those with relevant expertise, to explore and address issues related to medical products, policy, and surveillance methods and systems.

Amount: $3.5m total, 5 years

Due Date: June 11th, 2019

For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-19-013.html